Trials and PIs
View all posts »ACT Trial with Dr Otavio Berwanger
Nov 16, 2010 18:32 EST-
1Comments
-
Read later
Dr Otavio Berwanger (São Paulo Cardiac Hospital, Brazil) discusses Acetylcysteine for the Prevention of Contrast-Induced Nephropathy (ACT) Trial: A Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography with Dr Gabriel Steg.
Filmed during AHA 2010 in Chicago, IL on November 15.
See:
ACT: No benefit of N-acetylcysteine to reduce contrast-induced nephropathy
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
